Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Cell Death & Disease
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. cell death & disease
  3. articles
  4. article
Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 06 May 2026

Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems

  • Stefania Modafferi1,
  • Valentina Silenzi2,
  • Anna Garbelli1,
  • Gloria Lazoi1,
  • Eveljn Scarian3,
  • Sara D’Uva2,
  • Tiziana Santini2,
  • Adelaide Riccardi1,
  • Mauro Cozzolino  ORCID: orcid.org/0000-0003-0342-89614,
  • Orietta Pansarasa3,
  • Nadia D’Ambrosi  ORCID: orcid.org/0000-0002-6646-76535,
  • Simone Sabbioneda1,
  • Mariangela Morlando2 &
  • …
  • Sofia Francia  ORCID: orcid.org/0000-0002-4578-94421 

Cell Death & Disease (2026) Cite this article

  • 1531 Accesses

  • 7 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Double-strand DNA breaks
  • Protein aggregation

Abstract

Amyotrophic lateral sclerosis (ALS) is characterised by the aggregation of TDP-43 and mutant FUS in the cytoplasm of affected motor neurons. Accumulation of DNA damage is emerging as a novel correlative trait of ALS. We recently showed that formation of TDP-43 and FUS cytoplasmic inclusions (CIs) lead to DNA damage accumulation through dysregulation of the DNA damage response (DDR). However, the multiple molecular mechanisms contributing to DNA damage accumulation in affected motor neurons in ALS have not been fully elucidated. In recent years, chemical inhibition of the serine/threonine kinase CHK1 was shown to lead to accumulation of DNA breaks as well as increased apoptosis, in differentiated cortical neurons. Notably, CHK1 has been involved in DNA double-strand break repair in non-dividing cells, by acting through the histone chaperone ASF1A. In this article, we show that cells bearing FUS and TDP-43 CIs show downregulation of the protein levels of CHK1 and ASF1A. We observe CHK1 protein downregulation in neuronal cell lines, as well as in patient-derived motor neurons progenitors and in the spinal cord of a FUS-ALS mouse model. Restoration of the nuclear levels of CHK1 and ASF1A via transient overexpression, is sufficient to reduce DNA damage signal accumulation and rescues DDR defects. Importantly, we show that the ubiquitin-proteasome pathway is responsible for CHK1 degradation in cells bearing FUS CI, since its inhibition restores CHK1 and ASF1A protein levels. Our study demonstrates that proteasomal-dependent CHK1 and ASF1A downregulation contributes to accumulation of DNA damage in cells affected by ALS-linked protein aggregates.

Similar content being viewed by others

Proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial processes between human and mouse ALS models

Article Open access 30 September 2025

TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD

Article Open access 31 October 2025

Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD

Article Open access 03 April 2023

Acknowledgements

We would like to thank the Imaging Facility at the Center for Life Nano & NeuroScience, Istituto Italiano di Tecnologia@Rome and the Microscopy Facility, Department of Biology and Biotechnologies “C. Darwin”, Sapienza University of Rome (Sapienza Research Infrastructure) for technical support on image acquisition; Dr Sara Tavella (IGM-CNR, Pavia), Dr Ubaldo Gioia (IGM-CNR, Pavia), Dr Sara Sepe (IFOM, Milan) and Dr Fabrizio d’Adda di Fagagna (IGM-CNR, Pavia, IFOM, Milan) for their helpful advice and Dr Ornella Brandi (IGM-CNR) for generating the A382T TDP-43 and I383V TDP-43 constructs and for observing for the first time that cells with TDP-43 CIs have reduced level of total CHK1 protein, suggesting one initial hypothesis of this study. SM is supported by: Istituto Universitario di Studi Superiori (IUSS, Pavia, Itay); Istituto Superiore di Sanità RIPREI2023_7c8ae10d783c; Progetto AriSLA 2021 “DDR & ALS”; POR FESR 2014–20 Regione Lombardia (InterSLA project) (DSB.AD004.294). ES and OP are supported by Italian Ministry of Health (Ricerca Corrente 2025 - 2027). SDU and VS are supported by ERC-2019-SyG 855923-ASTRA. AG is supported by: POR FESR 2014-2020 Regione Lombardia (InterSLA project) (DSB.AD004.294); Italian Association for Cancer Research AIRC Investigator Grant IG2022-27833. NDA is supported by: Fondazione AriSLA ETS (Fondazione di Ricerca per la SLA ETS), SwitchALS project; #NEXTGENERATIONEU (NGEU) and founded by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006) – A Multiscale Integrated Approach to the Study of the Nervous System in Health and Disease (DN. 1553 11.10.2022). AR is supported by PRIN 2022 (2022R7LH5T). MC is supported by: Fondazione AriSLA ETS (Fondazione di ricerca per la SLA ETS), SwitchALS project; CNR (DBA.AD005.225-NUTRAGE-FOE2021). SS is supported by the Associazione Italiana per la Ricerca sul Cancro Investigator Grant IG-2020-24316; MUR PRIN 2017 (2017KSZZJW), MUR/PNRR Next Generation EU PRIN 2022 (2022JA8JY5), NUTRAGE CNR project FOE-2021 DBA.AD005.225. MM is supported by Fondo Ricerca Ateneo 2024 (n. RG12419107CD28D5) Università Sapienza di Roma. SF is supported by: AIRC Investigator Grant 2025 ID 32610; AriSLA full grant 2021 “DDR & ALS” 2016 “DDRNA &ALS”; PNRR-CN3 “National Center for Gene Therapy and Drugs based on RNA Technology”; Progetti di Ricerca di Interesse Nazionale (PRIN) 2017 (2017NWEXEP); PRIN 2020 (2020CXFL4T); PRIN 2022 (2022R7LH5T); POR FESR 2014-2020 Regione Lombardia (InterSLA project) (DSB.AD004.294); Progetto DONO ID6069058 “Collabora & Innova” Regione Lombardia; NUTRAGE CNR project FOE-2021 DBA.AD005.225.

Author information

Authors and Affiliations

  1. Institute of Molecular Genetics, National Research Council (CNR), Pavia, Italy

    Stefania Modafferi, Anna Garbelli, Gloria Lazoi, Adelaide Riccardi, Simone Sabbioneda & Sofia Francia

  2. Department of Biology and Biotechnologies “Charles Darwin”, Sapienza University of Rome, Rome, Italy

    Valentina Silenzi, Sara D’Uva, Tiziana Santini & Mariangela Morlando

  3. Cellular Models and Neuroepigenetics Section, IRCCS Mondino Foundation, Pavia, Italy

    Eveljn Scarian & Orietta Pansarasa

  4. Institute of Translational Pharmacology, CNR, Rome, Italy

    Mauro Cozzolino

  5. Department of Biology, University of Rome Tor Vergata, Rome, Italy

    Nadia D’Ambrosi

Authors
  1. Stefania Modafferi
    View author publications

    Search author on:PubMed Google Scholar

  2. Valentina Silenzi
    View author publications

    Search author on:PubMed Google Scholar

  3. Anna Garbelli
    View author publications

    Search author on:PubMed Google Scholar

  4. Gloria Lazoi
    View author publications

    Search author on:PubMed Google Scholar

  5. Eveljn Scarian
    View author publications

    Search author on:PubMed Google Scholar

  6. Sara D’Uva
    View author publications

    Search author on:PubMed Google Scholar

  7. Tiziana Santini
    View author publications

    Search author on:PubMed Google Scholar

  8. Adelaide Riccardi
    View author publications

    Search author on:PubMed Google Scholar

  9. Mauro Cozzolino
    View author publications

    Search author on:PubMed Google Scholar

  10. Orietta Pansarasa
    View author publications

    Search author on:PubMed Google Scholar

  11. Nadia D’Ambrosi
    View author publications

    Search author on:PubMed Google Scholar

  12. Simone Sabbioneda
    View author publications

    Search author on:PubMed Google Scholar

  13. Mariangela Morlando
    View author publications

    Search author on:PubMed Google Scholar

  14. Sofia Francia
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Sofia Francia.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

All activities that involve human subjects were conducted in accordance with the World Medical Association’s Declaration of Helsinki. The study design was examined by the ethical committee of the enrolling institutions (p-20180034329) (Approval date: 15/02/2021). Informed consent was obtained from all subjects involved in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Professor Wei-Na Jin

Supplementary information

Figure S1 (part 1) (download TIFF )

Figure S1 (part 2) (download TIFF )

Figure S2 (part 1) (download TIF )

Figure S2 (part 2) (download TIF )

Figure S3 (download TIF )

Figure S4 (part 1) (download TIF )

Figure S4 (part 2) (download TIF )

Figure S5 (part 1) (download TIF )

Figure S5 (part 2) (download TIF )

Original uncropped western blots and agarose gels (download PDF )

Supplementary figures legends (download DOCX )

Source data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Modafferi, S., Silenzi, V., Garbelli, A. et al. Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems. Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-08603-6

Download citation

  • Received: 06 August 2025

  • Revised: 18 February 2026

  • Accepted: 09 March 2026

  • Published: 06 May 2026

  • DOI: https://doi.org/10.1038/s41419-026-08603-6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • About the Editors
  • Open access publishing
  • Contact
  • For Advertisers
  • Press Releases
  • About the Partner
  • Upcoming Conferences

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Cell Death & Disease (Cell Death Dis)

ISSN 2041-4889 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited